Dr Andrew Stolz reports on the relationship between alterations to the ABCB11 gene and the risk of drug-induced liver injury from anabolic steroids.
This episode is part of the Independent Medical Education program entitled, 'Unveiling the Spectrum: A Deep Dive into Late-Onset Genetic Cholestatic'. This expert-led program will allow you to effectively recognize and diagnose late-onset genetic cholestasis, and make informed decisions on individualized patient management strategies, by providing education on disease presentation, the importance of genetic testing, symptom management, clinical guidelines, and new advances in the treatment landscape.
To learn more about the full program, visit rare-liver-disorders.ime.springerhealthcare.com/3-late-onset-genetic-cholestasis/
---
This program is made possible thanks to an independent educational grant from Ipsen.